Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar immune abnormalities, notably in the Th2 pathway, according to a study ...
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...
Scientists have zeroed in on a critical weak spot behind a rare but devastating brain autoimmune disorder often known as ...
Everyday Health on MSN
7 adjunctive medications to discuss when your bipolar mood stabilizer isn’t enough
When lithium or valproate aren't enough, ‘add-on’ treatments like atypical antipsychotics can help. Discover 7 options to discuss with your doctor.
The final, formatted version of the article will be published soon. Background: Bipolar depression remains a leading cause of morbidity, functional impairment, and suicide risk in bipolar disorder.
Some serious brain disorders begin with symptoms that are easy to misinterpret. A person may become confused, forgetful or paranoid and be treated for mental illness before doctors realize the ...
A new study published in Science Advances describes a potential target for therapies aimed at treating anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis, also known as ‘Brain on Fire,’ an ...
Your donation today will help MinnPost continue to report on the news you need. Depression treatment is not an exact science. In fact, about 30% of people diagnosed with major depressive disorder ...
Scientists have discovered that a single gene, GRIN2A, can directly cause mental illness—something previously thought to stem only from many genes acting together. People with certain variants of this ...
The links between neurons are crucial to the brain, and brain cells can reorganize the way they are linked together in a phenomenon known as neuroplasticity. This process is ongoing during a lifetime, ...
Uzedy administered once every 2 months is not recommended for the maintenance treatment of bipolar I disorder. The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results